Abstract
HOXC-AS3 is a low glucose-activated long noncoding RNA that triggers metabolic reprogramming in breast cancer cells to adapt to nutrient stress, identifying HOXC-AS3 as a potential therapeutic target for breast cancer treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have